scispace - formally typeset
H

Hideki Agata

Researcher at University of Tokyo

Publications -  26
Citations -  784

Hideki Agata is an academic researcher from University of Tokyo. The author has contributed to research in topics: Stromal cell & Bone marrow. The author has an hindex of 13, co-authored 25 publications receiving 718 citations. Previous affiliations of Hideki Agata include Nagoya University & Nagasaki University.

Papers
More filters
Journal ArticleDOI

Effective Bone Engineering with Periosteum-derived Cells

TL;DR: Combined treatment with bFGF and BMP-2 can make periosteum a highly useful source of bone regeneration, and compared the osteogenic potential of these cells to that of bone marrow stromal cells.
Journal ArticleDOI

Morphology-based prediction of osteogenic differentiation potential of human mesenchymal stem cells.

TL;DR: The results provide strong evidence for the feasibility of using a quantitative time series of phase-contrast cellular morphology for non-invasive cell quality prediction in regenerative medicine.
Journal ArticleDOI

Bone marrow stromal cells (bone marrow-derived multipotent mesenchymal stromal cells) for bone tissue engineering: basic science to clinical translation.

TL;DR: The nature of the cells, suitable culture conditions for bone tissue engineering, and their potential therapeutic applications are reviewed with possible caveats and recent advances in bone marrow stromal cell biology are discussed with reference to clinical translation.
Journal ArticleDOI

Feasibility and efficacy of bone tissue engineering using human bone marrow stromal cells cultivated in serum-free conditions

TL;DR: The feasibility and efficacy of bone tissue engineering with human bone marrow stromal cells (BMSCs) expanded in serum-free conditions is reported and as efficient as that obtained with BMSCs expanded in conventional serum-containing medium.
Journal ArticleDOI

Characteristic change and loss of in vivo osteogenic abilities of human bone marrow stromal cells during passage.

TL;DR: There are several required conditions for human BMSCs to demonstrate their bone-forming capabilities, which should be further investigated and considered when designing a protocol for clinical bone tissue engineering.